600267 海正药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额1,455,5801,502,6692,065,7371,736,5241,589,609
投资活动产生之现金流量净额(120,299)(338,706)(578,780)(493,284)1,007,748
筹资活动产生之现金流量净额(1,474,235)(1,004,207)(1,505,405)(2,074,013)(2,229,212)
汇率变动对现金及现金等价物的影响2,5984,7186,526(600)(20,262)
现金及现金等价物净增加/(减少)(136,357)164,474(11,922)(831,373)347,883
期初现金及现金等价物余额1,329,6231,165,1491,177,0712,008,4441,660,561
期末现金及现金等价物余额1,193,2661,329,6231,165,1491,177,0712,008,444